Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Calponin may modulate cardiac thin-filament regulation; leaves open its role in human contractile disorders.
Calponin, an actin-binding protein, inhibited the acto-heavy meromyosin (HMM) MgATPase and lowered the binding of HMM to actin. The amount of calponin bound to actin or tropomyosin-actin was the same when the ATPase was inhibited 80-90%. While the KATPase was diminished only less than 2-fold in the presence of calponin, the Vmax was decreased 6-fold and 2-fold with actin and tropomyosin-actin, respectively. A comparison of the kinetic constants for the ATP hydrolysis obtained in the presence of actin-calponin and tropomyosin-actin-calponin revealed that the tropomyosin augmented the Vmax 5-fold from the inhibited level, but there was no effect on the KATPase.
No takes yet. Share an insight, caveat, or question.
Horiuchi et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: